LT
Lycia Therapeutics, Inc.
SEC filingBiotechnology · South San Francisco, CA
Amount raised$75Msold at filing
Total offering$75M
Investors in the raise16count reported to the SEC
FiledJun 25, 2026first sale Jun 10, 2026
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Tim AndersonDirector
William RieflinDirector
Clare OzawaDirector
Aetna Wun TrombleyExecutive Officer, Director
Laurent FischerDirector
Ming FangDirector
Amy BachrodtExecutive Officer
Executive officers, directors and promoters as listed on the Form D.